DGAP-Adhoc
aap Implantate AG resolves on capital increase with subscription rights to finance sales growth and start of human clinical study for antibacterial silver coating technology - Seite 2
The capital increase with subscription rights is accompanied by BankM AG. For further details regarding the transaction please refer to the subscription offer, which will be published before the
start of the subscription period on the corporate website of the Company (https://www.aap.de/) in the section "Investors / Capital Increase" as well as in the Federal Gazette under
https://www.bundesanzeiger.de/.
Lesen Sie auch
----------------------------------------------------------------
aap Implantate AG (ISIN DE0005066609) - General Standard/Regulated Market - All German stock markets -
About aap Implantate AG
aap Implantate AG is a globally active medical technology company based in Berlin, Germany. The Company develops, manufactures and markets products for trauma. The IP-protected portfolio
includes besides the innovative anatomical plating system LOQTEQ(R) a wide range of cannulated screws. In addition, aap Implantate AG has an innovation pipeline with promising development
projects such as the antibacterial silver coating technology and magnesium-based implants. These technologies address critical and unmet needs in trauma. In Germany, aap Implantate AG sells
its products directly to hospitals, purchasing groups, and hospital groups, while at international level it primarily uses a broad network of distributors in around 25 countries. In the US the
Company pursues a hybrid distribution strategy with its subsidiary aap Implants Inc. Distribution is carried out both through distribution agents and partnerships with global orthopedic
companies. aap Implantate AG's stock is listed in the General Standard segment of Frankfurt Stock Exchange (XETRA: AAQ.DE). For more information, please visit our website at www.aap.de.
Forward-looking statement
This release may contain forward-looking statements based on current experience, estimates and projections of the management board and currently available information. They are not guarantees of
future performance. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or
performance of the company and the estimates given here. Many factors could cause the actual results, performance or achievements of aap to be materially different from those that may be
expressed or implied by such statements. These factors include those discussed in aap's public reports. Forward-looking statements therefore speak only as of the date they are made.
aap does not assume any obligation to update the forward-looking statements contained in this release or to conform them to future events or developments.